Clinical Trial Update: Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating cisplatin plus etoposide with or without paclitaxel in extensive-stage small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED